Acrolein as a novel therapeutic target for motor and sensory deficits in spinal cord injury
Authors:
Open Access
- 1 January 2014
- journal article
- research article
- Published by Medknow in Neural Regeneration Research
- Vol. 9 (7) , 677-83
Abstract
In the hours to weeks following traumatic spinal cord injuries (SCI), biochemical processes are initiated that further damage the tissue within and surrounding the initial injury site: a process termed secondary injury. Acrolein, a highly reactive unsaturated aldehyde, has been shown to play a major role in the secondary injury by contributing significantly to both motor and sensory deficits. In particular, efforts have been made to elucidate the mechanisms of acrolein-mediated damage at the cellular level and the resulting paralysis and neuropathic pain. In this review, we will highlight the recent developments in the understanding of the mechanisms of acrolein in motor and sensory dysfunction in animal models of SCI. We will also discuss the therapeutic benefits of using acrolein scavengers to attenuate acrolein-mediated neuronal damage following SCI.Keywords
This publication has 55 references indexed in Scilit:
- Acrolein‐mediated injury in nervous system trauma and diseasesMolecular Nutrition & Food Research, 2011
- Acrolein scavengers: Reactivity, mechanism and impact on healthMolecular Nutrition & Food Research, 2011
- Direct Analysis of Biological Tissue by Paper Spray Mass SpectrometryAnalytical Chemistry, 2011
- Compression Induces Acute Demyelination and Potassium Channel Exposure in Spinal CordJournal of Neurotrauma, 2010
- Importance of the vasculature in cyst formation after spinal cord injuryJournal of Neurosurgery: Spine, 2009
- Critical role of acrolein in secondary injury following ex vivo spinal cord traumaJournal of Neurochemistry, 2008
- The mitochondrial impairment, oxidative stress and neurodegeneration connection: reality or just an attractive hypothesis?Trends in Neurosciences, 2008
- Monocyte chemoattractant protein‐1 functions as a neuromodulator in dorsal root ganglia neuronsJournal of Neurochemistry, 2007
- 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1Proceedings of the National Academy of Sciences, 2007
- Hydralazine Inhibits Rapid Acrolein-Induced Protein Oligomerization: Role of Aldehyde Scavenging and Adduct Trapping in Cross-Link Blocking and CytoprotectionMolecular Pharmacology, 2006